Zydus receives final approval from the USFDA for Atenolol and Chlorthalidone Tablets USP

Deepthi | Myequity news | Date : 12-03-2019 12:56:00 IST


Zydus Cadila
has received the final approval from the USFDA to market Atenolol and Chlorthalidone Tablets USP (USRLD Tenoretic®), 50mg/25mg and 100mg/25mg. It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad.

About Zydus Cadila

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.


More from Myequity